Purine-mediated signalling in pain and visceral perception

Trends Pharmacol Sci. 2001 Apr;22(4):182-8. doi: 10.1016/s0165-6147(00)01643-6.

Abstract

Receptor subtypes for purines have been identified in a variety of tissues, increasing interest in the roles of purine-mediated signalling in pathophysiological processes. Growing evidence supports the involvement of one of the purinoceptor subtypes, P2X3, in nociception. In this article, recent studies of purine-mediated nociception and visceral pain will be discussed. Furthermore, a novel hypothesis is proposed for purine-mediated mechanosensory transduction where ATP released during distension from epithelial cells lining tubes (such as ureter and gut) and sacs (such as the bladder) acts on P2X3 receptors on a subepithelial nerve plexus to initiate impulses that are relayed via the spinal cord to pain centres in the brain.

MeSH terms

  • Animals
  • Humans
  • Pain / etiology*
  • Purinergic Agonists
  • Purinergic Antagonists
  • Receptors, Purinergic* / classification
  • Receptors, Purinergic* / physiology
  • Signal Transduction / physiology*

Substances

  • Purinergic Agonists
  • Purinergic Antagonists
  • Receptors, Purinergic